Marrow ring sideroblasts are highly predictive for TP53 mutation in MDS with excess blasts

Affiliations

• ¹ Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
• ² Tampa General Hospital Cancer Institute, Tampa, FL, USA.
• ³ Department of Hematopathology and Molecular Diagnostics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ⁴ Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
• ⁵ Department of Hematology, CHU of Nice, Nice, France.
• ⁶ Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
• ⁷ Department of Medicine, University of South Florida, Tampa, FL, USA.
• ⁸ Department of Internal Medicine, Mass General Brigham Salem Hospital, Boston, MA, USA.
• ⁹ Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
• ¹⁰ Department of Hematology and Medical Oncology, Weill Cornell Medical College, New York, NY, USA.
• ¹¹ Department of Pathology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
• ¹² Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA. David.Sallman@moffitt.org.